Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neurobiology of Aging

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2018.01.021PMID 29501959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial diseases: the contribution of organelle stress responses to pathology

  2017cited by this paper
• Skin disorders in Parkinson’s disease: potential biomarkers and risk factors

  2017cited by this paper
• Plasma α-synuclein predicts cognitive decline in Parkinson’s disease

  2017cited by this paper
• Parkin regulation of CHOP modulates susceptibility to cardiac endoplasmic reticulum stress

  2017cited by this paper
• Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene

  2017cited by this paper
• LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1

  2016cited by this paper
• Mitochondrial DNA Replication Defects Disturb Cellular dNTP Pools and Remodel One-Carbon Metabolism.

  2016cited by this paper
• Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.

  2016cited by this paper
• Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation

  2016cited by this paper
• Exploring the Association Between Rosacea and Parkinson Disease: A Danish Nationwide Cohort Study.

  2016cited by this paper
• Transcriptome profiling in Parkinson's leukocytes: from early diagnostics to neuroimmune therapeutic prospects.

  2016cited by this paper
• Parkin Regulation and Neurodegenerative Disorders

  2016cited by this paper
• The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.

  2015cited by this paper
• Structural and Functional Impact of Parkinson Disease‐Associated Mutations in the E3 Ubiquitin Ligase Parkin

  2015cited by this paper
• Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients

  2015cited by this paper
• Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models

  2015cited by this paper
• Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions

  2015cited by this paper
• Parkin Mutations Reduce the Complexity of Neuronal Processes in iPSC‐Derived Human Neurons

  2015cited by this paper
• Parkin structure and function

  2015cited by this paper
• Can folic acid have a role in mitochondrial disorders?

  2015cited by this paper
• Altered protein expression pattern in skin fibroblasts from parkin-mutant early-onset Parkinson's disease patients.

  2015cited by this paper
• The MC1R melanoma risk variant p.R160W is associated with Parkinson disease

  2015cited by this paper
• Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls.

  2015cited by this paper
• The Parkinson’s Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway

  2015cited by this paper
• Genetics of Parkinson's disease--state of the art, 2013.

  2014cited by this paper
• Axon guidance and injury-lessons from Wnts and Wnt signaling.

  2014cited by this paper
• G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy.

  2014cited by this paper
• Serine and glycine metabolism in cancer☆

  2014cited by this paper
• Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson’s disease

  2014cited by this paper
• Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease.

  2014cited by this paper
• Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease

  2014cited by this paper
• A laboratory-based study on patients with Parkinson’s disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production

  2014cited by this paper
• Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease.

  2014cited by this paper
• Interactions between cell adhesion and the synaptic vesicle cycle in Parkinson's disease.

  2014cited by this paper
• Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription.

  2013cited by this paper
• High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy

  2013cited by this paper
• Robustly detecting differential expression in RNA sequencing data using observation weights

  2013cited by this paper
• Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization

  2013cited by this paper
• Parkin promotes cell survival via linear ubiquitination

  2013cited by this paper
• Seborrheic Dermatitis and Risk of Future Parkinson's Disease (PD) (S42.001)

  2012cited by this paper
• The GEM mapper: fast, accurate and versatile alignment by filtration

  2012cited by this paper
• Genetics of Parkinson's disease.

  2012cited by this paper
• G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization

  2012cited by this paper
• Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study

  2012cited by this paper
• Notch signaling and neural connectivity.

  2012cited by this paper
• Wnt signaling in the vertebrate central nervous system: from axon guidance to synaptic function.

  2012cited by this paper
• Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers.

  2012cited by this paper
• Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease.

  2012cited by this paper
• GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics

  2012cited by this paper
• Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease.

  2012cited by this paper
• Primary Skin Fibroblasts as a Model of Parkinson's Disease

  2012cited by this paper
• Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson’s Disease Patient Fibroblasts

  2012cited by this paper
• Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue

  2012cited by this paper
• Notch signaling inhibits axon regeneration.

  2012cited by this paper
• Phosphatase and Tensin Homolog (PTEN)-induced Putative Kinase 1 (PINK1)-dependent Ubiquitination of Endogenous Parkin Attenuates Mitophagy

  2012cited by this paper
• The importance of Wnt signalling for neurodegeneration in Parkinson's disease.

  2012cited by this paper
• Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration

  2012cited by this paper
• Meta-analysis of the relationship between Parkinson disease and melanoma

  2011cited by this paper
• Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.

  2011cited by this paper
• Variance of Gene Expression Identifies Altered Network Constraints in Neurological Disease

  2011cited by this paper
• Multi-organ autonomic dysfunction in Parkinson disease.

  2011cited by this paper
• Expression analysis of dopaminergic neurons in Parkinson’s disease and aging links transcriptional dysregulation of energy metabolism to cell death

  2011cited by this paper
• PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

  2010cited by this paper
• Transcriptome genetics using second generation sequencing in a Caucasian population

  2010cited by this paper
• Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease

  2010cited by this paper
• Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts

  2010cited by this paper
• A scaling normalization method for differential expression analysis of RNA-seq data

  2010cited by this paper
• Mitochondrial abnormalities in the putamen in Parkinson’s disease dyskinesia

  2010cited by this paper
• Compartmentalization of Mammalian folate-mediated one-carbon metabolism.

  2010cited by this paper
• Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

  2010cited by this paper
• Parkin Enhances the Expression of Cyclin-dependent Kinase 6 and Negatively Regulates the Proliferation of Breast Cancer Cells*

  2010cited by this paper
• Disease-specific, neurosphere-derived cells as models for brain disorders

  2010cited by this paper
• Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2

  2010cited by this paper
• Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson´s disease

  2009cited by this paper
• Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.

  2009cited by this paper
• GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information

  2009cited by this paper
• Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease

  2009cited by this paper
• Lesions outside the CNS in Parkinson's disease

  2009cited by this paper
• Epidemiology of Parkinson’s disease

  2008cited by this paper
• Mitochondrial function and morphology are impaired in parkin‐mutant fibroblasts

  2008cited by this paper
• Neuronal gene expression correlates of Parkinson's disease with dementia

  2008cited by this paper
• Parkinson patient fibroblasts show increased alpha-synuclein expression.

  2008cited by this paper
• TRB3 Inhibits the Transcriptional Activation of Stress-regulated Genes by a Negative Feedback on the ATF4 Pathway*

  2007cited by this paper
• Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and Aggregation*

  2007cited by this paper
• The role of cell adhesion molecules in axon growth and guidance.

  2007cited by this paper
• Molecular markers of early Parkinson's disease based on gene expression in blood

  2007cited by this paper
• The medial and lateral substantia nigra in Parkinson’s disease: mRNA profiles associated with higher brain tissue vulnerability

  2007cited by this paper
• GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists

  2007cited by this paper
• Skin biopsy for assessment of autonomic denervation in Parkinson’s disease

  2006cited by this paper
• Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of paediatric patients: reference values for a paediatric population.

  2006cited by this paper
• Epidemiology of Parkinson's disease.

  2006cited by this paper
• Parkin Modulates Gene Expression in Control and Ceramide-Treated PC12 Cells

  2006cited by this paper
• Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson’s disease

  2006cited by this paper
• Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

  2006cited by this paper
• Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin

  2006cited by this paper
• Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease.

  2006cited by this paper
• Case-control study of the parkin gene in early-onset Parkinson disease.

  2006cited by this paper
• Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes

  2005cited by this paper
• Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms

  2005cited by this paper
• Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.

  2005cited by this paper

• Parkin characteristics and blood biomarkers of Parkinson’s disease in WPBLC study

  2025cites this paper
• A Systematic Review of Extracellular Matrix-Related Alterations in Parkinson’s Disease

  2024cites this paper
• Mitochondrial Inorganic Polyphosphate (polyP) Is a Potent Regulator of Mammalian Bioenergetics in SH-SY5Y Cells: A Proteomics and Metabolomics Study

  2022cites this paper
• Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency

  2021cites this paper
• Multitasking guardian of mitochondrial quality: Parkin function and Parkinson’s disease

  2021cites this paper
• Neuronal induction and bioenergetics characterization of human forearm adipose stem cells from Parkinson’s disease patients and healthy controls

  2021cites this paper
• Resveratrol Treatment in Human Parkin-Mutant Fibroblasts Modulates cAMP and Calcium Homeostasis Regulating the Expression of Mitochondria-Associated Membranes Resident Proteins

  2021cites this paper
• Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels

  2021cites this paper
• Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels

  2021cites this paper
• Expanding the search for genetic biomarkers of Parkinson's disease into the living brain.

  2020cites this paper
• Nuclear Parkin Activates the ERRα Transcriptional Program and Drives Widespread Changes in Gene Expression Following Hypoxia

  2020cites this paper
• Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration

  2019cites this paper
• Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations

  2019cites this paper
• The Transcription Factor Function of Parkin: Breaking the Dogma

  2019cites this paper
• Parkinson’s disease as a systemic pathology

  2019cites this paper
• Mitohormesis and autophagic balance in Parkinson disease

  2019cites this paper